Results 191 to 200 of about 47,222 (292)
Enhancing Medication Adherence in Older Adults: A Systematic Review of Evidence‐Based Strategies
Journal of the American Geriatrics Society, EarlyView.Designing and implementing an intervention aimed at improving adherence in older subjects. ABSTRACT Background
Medication adherence is essential for achieving favorable health outcomes, particularly in older adults with multiple chronic conditions.Stefano Scotti, Luca Pasina, Carlotta Lunghi, Emanuel Raschi, Andrea Rossi, Elena Olmastroni, Marco Salluzzo, Sara Mucherino, Valentina Orlando, Alessandro Nobili, Enrica Menditto, Elisabetta Poluzzi, Manuela Casula +12 morewiley +1 more sourceCardiovascular disease Multimorbidity is Associated with Decreased Health-Related Quality of Life in Haiti: Findings from a Population-based Cohort [PDF]
Shalom Sabwa, Vanessa Rouzier, Rodney Sufra, Reichling St Sauveur, Nour Mourra, Rehana Rasul, Joseph Inddy, Lily D. Yan, Madeline R. Sterling, Laura C. Pinheiro, Marie Deschamps, Jean W. Pape, Margaret L. McNairy +12 moreopenalex +1 more sourceEfficacy of a Multicomponent Intervention for Frailty or Physical Function in Prefrail or Frail Older Adults: FRAILMERIT Multicenter Clinical Trial
Journal of the American Geriatrics Society, EarlyView.Clinical management of the older adult. ABSTRACT Objectives
Frailty is a common condition in community‐dwelling older adults with high health and socioeconomic implications. However, primary care‐led randomized trials have been scarcely tested. Design
Multicenter cluster randomized clinical trial.Adriana Abizanda Saro, Rafael García Molina, Rubén Alcantud Córcoles, Manuel Maestre Moreno, Raúl Sánchez Uceda, Ignacio Morón Merchante, Antonio Aragonés Jiménez, María Dolores González Céspedes, Pilar Montero Alía, Marta Simarro Rueda, Luis Torres Antón, Pilar Martínez García, Humberto Soriano Fernández, Marta Córcoles García, Ángel Moises Reyes Abreu, María Nuria Morcillo González, Elena García Páez, Beatriz Rodríguez Sánchez, Marta Sáez Blesa, Elisa Belén Cortés Zamora, Fernando Andrés Pretel, Almudena Avendaño Céspedes, FRAILMERIT Study Group, Aránzazu Rodríguez Ortiz, Raquel González Herreros, José Luis Carboneras Atienza, Lisbeth Rodríguez Gómez, Hugo García López, Clotilde Boix Gras, Lorena Moreno Hernández, Jesús López‐Torres Hidalgo, Maximiliano Martínez Ramírez, Francisco Escobar Rabadán, Juan Manuel Téllez Lapeira, Esther Limón Romero, Clara Soler Gimbernat, Laura Grimal Abejez, Mercé Jioménez González, Verónica Griselda Echenique Portillo, Alexandre Ortega Roca, Meritxell Carmona Cervelló, Carla Chacón Valera, Carmen Rodríguez Buza, Óscar Cobos Cano, María Julia Sánchez Maestre, Ana Fons Diaz, Javier Ibáñez Rivas, Marina Carmona García, Inmaculada Sag Lesmes, Alfredo Ortiz Arjona, Alejandro Becerra Serrano, Antonia Prieto Cuesta, Ana Sánchez Maestre, Carlos Eusebio Esparza Ferrera, Miriam Bueno León, Cristina Figueroa Martín, Noelia Díaz Hernández, Patricia Gutiérrez González, Quintina Pérez Quesada, Soraya Sotto Rodríguez, Guacimara Delgado Jiménez, María Florentina Álvarez Álvarez, Yudanis Sánchez Alpízar, Diego Aparicio Barrilero, Paloma de Teodoro Idiago, Sandra Benito Prieto, Ana Pilar Javierre Miranda, Elena Mendoza Fernández, Emma Camino Ortega, Ana de Baroja Gil deGómez, María Lafuente Yanguas, Antía Codina Rodríguez, Amelia González Gamarra, José Gutiérrez Rodríguez, José Miguel Arche Coto, Eva López Alvarez, Alvaro Revuelta Argomaniz, Cristina Alonso Bouzón, José Antonio Serra Rexach, Jennifer Mayordomo Cava, Marta Carolina Ruiz Grao, Luis Aguilar Salmerón, Alicia Noguerón García, Elena Martín Sebastiá, Elena Gómez Jiménez, Cristina Gómez Ballesteros, Pedro Abizanda +86 morewiley +1 more sourceThe “Reducing Inflammation for Greater Health Trial (RIGHT)” Study—Concept, Rationale, and Design
Journal of the American Geriatrics Society, EarlyView.ABSTRACT
The Reducing Inflammation for Greater Health Trial's (RIGHT) study is a single‐center, randomized, double‐blind, placebo‐controlled trial designed to test whether clazkizumab, an interleukin‐6 (IL‐6) inhibitor, can improve or slow decline in physical, cognitive, and vascular function in older adults, when compared to a placebo.Sebastian E. Sattui, Marnie Bertolet, Daniel E. Forman, Michelle E. Danielson, Shanshan Yao, Oscar L. Lopez, Nancy W. Glynn, Neelesh K. Nadkarni, Akira Sekikawa, Tullia C. Bruno, Toren Finkel, Anne B. Newman +11 morewiley +1 more sourceThe Ariadne principles: how to handle multimorbidity in primary care consultations [PDF]
, 2014 Christiane Muth, Marjan van den Akker, Jeanet W. Blom, Christian Mallen, Justine Rochon, François Schellevis, Annette Becker, Martin Beyer, Jochen Gensichen, Hanna Kirchner, Rafael Perera, Alexandra Prados‐Torres, Martin Scherer, Ulrich Thiem, Hendrik van den Bussche, Paul Glasziou +15 moreopenalex +1 more source
